Ther-Rx and Perrigo announced that Gynazole-1 (butaconazole nitrate) vaginal cream 2% is now available again. Gynazole-1 cream is indicated for the local treatment of vulvovaginal candidiasis (infections caused by Candida) in non-pregnant women.
Butaconazole nitrate is presumed to inhibit the conversion of lanosterol to ergosterol, resulting in a change in fungal cell membrane lipid composition. This alters the cell permeability and, ultimately, results in osmotic disruption or growth inhibition.
Gynazole-1 2% is available in cartons containing one single-dose prefilled disposable applicator.
For more information call (877) 567-7676 or visit www.gynazole-1.com